Antibody-drug conjugates are receiving unrivaled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and ...

After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...

PECO Phillips Edison & Company, Inc.

China will ban the production of mercury thermometers and sphygmomanometers nationwide starting in 2026, according to a recent statement issued by National Medical Products Administration. In line ...